Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.6%

50 terminated/withdrawn out of 432 trials

Success Rate

80.8%

-5.8% vs industry average

Late-Stage Pipeline

8%

33 trials in Phase 3/4

Results Transparency

3%

6 of 211 completed trials have results

Key Signals

88 recruiting6 with results28 terminated22 withdrawn

Enrollment reporting

Analytics

N/A
249(72.0%)
Phase 2
35(10.1%)
Phase 4
18(5.2%)
Phase 3
15(4.3%)
Phase 1
13(3.8%)
Phase 1/2
11(3.2%)
Phase 2/3
3(0.9%)
Early Phase 1
2(0.6%)
346Total
N/A(249)
Phase 2(35)
Phase 4(18)
Phase 3(15)
+4 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (432)

Showing 20 of 432 trials
NCT07516210Phase 2Not Yet Recruiting

Adaptive Radiotherapy for Safe Hypofractionation

Role: lead

NCT06599658Phase 2Recruiting

COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Role: collaborator

NCT02084745Not ApplicableRecruiting

Timing of Glaucoma Drainage Device With Boston Keratoprosthesis

Role: lead

NCT04339907Not ApplicableRecruiting

Inflammatory Mediators of Glaucoma After Corneal Transplantation (AH-Tears)

Role: lead

NCT05805319Not ApplicableRecruiting

Dietary Intervention for NSCLC Patients Treated With ICI

Role: lead

NCT06831539Phase 1Completed

Impact of PEG Bowel Preparation on Gut Microbiome Composition Recovery

Role: lead

NCT07063602Recruiting

Sensory Anesthesia Achieved Through Different Paravertebral Block Approaches for Post-Op Pain Management After VATS Lung Resection

Role: lead

NCT07792707Not ApplicableNot Yet Recruiting

Structured Hemodynamic Assessment to Guide Care After Cardiac Surgery

Role: lead

NCT07837674Not ApplicableNot Yet Recruiting

Impact of Intravenous Dexamethasone on the Duration of Motor and Sensory Block Following Spinal Anesthesia With Chloroprocaine

Role: lead

NCT07850557Not Yet Recruiting

Hypertrophic Scar Prosthetic Pressure in Burn Amputee

Role: lead

NCT05785065Phase 2Recruiting

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

Role: lead

NCT04405401Phase 2Terminated

Stereotactic Ablative Radiotherapy for Oligo-Progressive Non Small Cell Lung Cancer

Role: lead

NCT07837687Not ApplicableNot Yet Recruiting

Effect of Paraffin Wax on Joint Contractures

Role: lead

NCT07783620Phase 1Not Yet Recruiting

Treatment of Stage IV Cancer Patients With Multiple Patient-specific Mutated Cell Surface Proteins With Chimeric Antibodies

Role: lead

NCT05244278Not ApplicableRecruiting

Artificial Intelligence (AI) Assisted Real-time Adenoma Detection and Classification During Colonoscopies

Role: lead

NCT06059378Not ApplicableActive Not Recruiting

Using AI-assisted Optical Polyp Diagnosis for Diminutive Colorectal Polyps

Role: lead

NCT06543862Not ApplicableRecruiting

Autonomous Artificial Intelligence Versus AI Assisted Human Optical Diagnosis

Role: lead

NCT05355363Not ApplicableCompleted

Risk of Metachronous Findings After Detection of Serrated Lesions and High-grade Dysplasia With Surveillance Delay

Role: lead

NCT06271941Not ApplicableRecruiting

Reducing Neoplasia Recurrence After Endoscopic Resection of Large Colorectal Polyps

Role: lead

NCT04409340Recruiting

Viscoelasticity Imaging to Assess Liver Cancer

Role: lead